Role of Antimicrobial Peptides Expressed by Host Cells Upon Infection by Helicobacter pylori

Author(s): Ramamourthy Gopal, Eunsil Jeong, Chang Ho Seo, Yoonkyung Park

Journal Name: Protein & Peptide Letters

Volume 21 , Issue 10 , 2014

Become EABM
Become Reviewer
Call for Editor


Colonization of the stomach by Helicobacter pylori can result in such gastrointestinal illnesses as chronic gastritis, peptic ulcer and gastric cancer. Antimicrobial peptides (AMPs) are expressed in the stomach and play a key role in the innate immune responses to H. pylori in humans. During H. pylori infections, AMP expression mediated by NOD-1, NF-kB and/or ERK, functions to eradicate the bacteria, thereby preventing the gastritis and gastric cancer. This suggests that the use of synthetic AMPs could be one component of an effective therapeutic strategy to combat H. pylori. In addition, it appears that some peptides, and combinations of peptides, act synergistically with conventional drugs, thereby enhancing therapeutic efficacy. Our aim in this article was to review what is currently known about gastric AMP expression in response to H. pylori infection, and to briefly discuss the potential use of AMPs, either alone or in combination with conventional antibiotics, for the treatment of H. pylori infection.

Keywords: Antimicrobial peptides, gastrointestinal illnesses, Helicobacter pylori, synergy effect, therapeutic efficacy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 04 September, 2014
Page: [1057 - 1064]
Pages: 8
DOI: 10.2174/0929866521666140708092032
Price: $65

Article Metrics

PDF: 36